Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Metabolic Risk in Childhood Brain Cancer Survivors with Childhood-Onset Growth Hormone Deficiency.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

IL-1β/CXCL12 signalling orchestrates adipocyte-pancreatic neuroendocrine tumor crosstalk.

Journal of translational medicine·2026
Same author

Targeted therapies in thoracic neuroendocrine tumors: challenges and failures of tyrosine kinase inhibition in lung and thymic carcinoids.

Expert opinion on pharmacotherapy·2026
Same author

Diet plays a supportive role in managing thyroid disorders - but a critical one!

European thyroid journal·2026
Same author

ERAS thyroidectomy within the Italian DRG-based public health system: surgical efficiency is penalized.

Updates in surgery·2026
Same author

How genetic/genomic/epigenetic changed or will change the diagnosis and management of endocrine disorders?

Annales d'endocrinologie·2026

Related Experiment Video

Updated: Jul 5, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Central hypothyroidism.

Andrea Lania1, Luca Persani, Paolo Beck-Peccoz

  • 1Department of Medical Sciences, Fondazione Ospedale Maggiore Policlinico IRCCS, University of Milan, Milan, Italy.

Pituitary
|April 17, 2008
PubMed
Summary
This summary is machine-generated.

Central hypothyroidism (CH) is a rare thyroid condition caused by pituitary or hypothalamic issues. Treatment involves levothyroxine therapy, carefully adjusting dosage to maintain normal free thyroxine (FT4) levels for optimal health outcomes.

Related Experiment Videos

Last Updated: Jul 5, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Area of Science:

  • Endocrinology
  • Thyroidology
  • Hormone Replacement Therapy

Background:

  • Central hypothyroidism (CH) is a rare endocrine disorder resulting from inadequate thyroid gland stimulation.
  • It stems from pituitary (secondary) or hypothalamic (tertiary) dysfunction.
  • Diagnosis is indicated by low thyroid hormones with inappropriately normal or low TSH levels.

Purpose of the Study:

  • To summarize the diagnostic and therapeutic principles of central hypothyroidism.
  • To highlight the importance of maintaining euthyroid status in CH patients.

Main Methods:

  • Review of diagnostic criteria for CH, focusing on thyroid hormone and TSH levels.
  • Evaluation of standard treatment protocols for CH, primarily levothyroxine (L-T4) therapy.
  • Emphasis on individualized L-T4 dosage adjustment based on FT4 levels.

Main Results:

  • CH diagnosis relies on identifying low thyroid hormones alongside non-suppressed TSH.
  • Levothyroxine (L-T4) therapy is the mainstay treatment for CH.
  • Therapeutic success is measured by achieving and maintaining normal circulating FT4 levels.

Conclusions:

  • Effective management of CH necessitates restoring and maintaining euthyroidism.
  • Standard levothyroxine therapy, guided by FT4 monitoring, is effective for the majority of CH patients.